Basic Information
Basic information for LINC00662-202-24aa
Peptide Name LINC00662-202-24aa
Genome Position chr19:27793004-27793075[-]
Species Human
Peptide Sequence MRSAAPFYGQGRRSACKSTQSLVT
Peptide Length 24
Unique No (LINC00662-204-24aa,LINC00662-209-24aa,LINC00662-224-24aa,LINC00662-225-24aa,LINC00662-226-24aa,LINC00662-231-24aa,LINC00662-232-24aa,LINC00662-237-24aa-1,LINC00662-240-24aa,LINC00662-242-24aa,LINC00662-243-24aa,LINC00662-244-24aa,LINC00662-245-24aa,LINC00662-247-24aa,LINC00662-248-24aa,LINC00662-249-24aa,LINC00662-251-24aa,LINC00662-252-24aa,LINC00662-255-24aa,LINC00662-257-24aa,LINC00662-259-24aa,LINC00662-263-24aa-2,LINC00662-265-24aa,LINC00662-268-24aa,LINC00662-277-24aa)
Grand Average of Hydropathicity -0.5042
Relative Molecular Mass 3017.38
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000261824;LINC00662
Transcript ID/Name ENST00000586248;LINC00662-202
Transcript Length 669
Coding Ability 0.0433
DNA Sequence Corresponding to Peptide ATGCGCAGTGCTGCCCCTTTCTATGGGCAGGGCCGAAGGTCCGCGTGTAAAAGTACCCAGTCCCTGGTAACC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :